Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica

• National Institute for Medical Research (TZ)

• Nnamdi Azikiwe University Teaching Hospital (NG)

tel qu’imprimé : Chide E. Okocha

• University of Abuja (NG)

tel qu’imprimé : Samuel A. Asala

• University of Cape Town (ZA)

• University of Cape Town (ZA)

• South African Medical Research Council (ZA)
• University of Cape Town (ZA)

tel qu’imprimé : Andre P. Kengne

• Institute of Infectious Disease and Molecular Medicine (ZA)
• University of Cape Town (ZA)

tel qu’imprimé : Emile R. Chimusa

• University of Cape Town (ZA)

• University of Abuja (NG)

tel qu’imprimé : Hezekiah A. Isa

• University of Abuja Teaching Hospital (NG)

tel qu’imprimé : Uche Nnebe-Agumadu

tel qu’imprimé : Adekunle D. Adekile

• Kwame Nkrumah University of Science and Technology (GH)

tel qu’imprimé : Alex Osei-Akoto

tel qu’imprimé : Kwaku Ohene-Frempong

• Muhimbili University of Health and Allied Sciences (TZ)

• University of Abuja (NG)

tel qu’imprimé : Obiageli E. Nnodu

• Institute of Infectious Disease and Molecular Medicine (ZA)
• University of Cape Town (ZA)

• Muhimbili University of Health and Allied Sciences (TZ)